Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study-Reference-Cited by-同舟云学术

Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia: A report from the BINGO study

Published:2010-07-01 Issue:10 Volume:101 Page:2186-2192
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:

Author:

Ishikawa Yuichi,Kiyoi Hitoshi,Watanabe Keisuke,Miyamura Koichi,Nakano Yasuyuki,Kitamura Kunio,Kohno Akio,Sugiura Isamu,Yokozawa Toshiya,Hanamura Akitoshi,Yamamoto Kazuhito,Iida Hiroatsu,Emi Nobuhiko,Suzuki Ritsuro,Ohnishi Kazunori,Naoe Tomoki

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1349-7006.2010.01643.x/fullpdf

Reference32 articles.

1. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia;Druker;N Engl J Med,2001

2. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;O’Brien;N Engl J Med,2003

3. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia;Druker;N Engl J Med,2006

4. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet;Baccarani;Blood,2006

5. How I treat chronic myeloid leukemia in the imatinib era;Goldman;Blood,2007

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive performance of population pharmacokinetic models of imatinib in chronic myeloid leukemia patients;Cancer Chemotherapy and Pharmacology;2024-03-05

2. Application of physiologically based pharmacokinetic modeling to understand real‐world outcomes in patients receiving imatinib for chronic myeloid leukemia;Pharmacology Research & Perspectives;2023-07-07

3. Impact of surgical resection for gastrointestinal stromal tumor (GIST) patients with initially diagnosed synchronous hepatic metastases on long-term survival outcomes;Digestive and Liver Disease;2023-04

4. Prevalence of therapeutic drug monitoring and adherence to imatinib in chronic myeloid leukemia in Japan;Int. Journal of Clinical Pharmacology and Therapeutics;2022-11-01

5. Real‐world efficacy and safety outcomes of imatinib treatment in patients with chronic myeloid leukemia: An Australian experience;Pharmacology Research & Perspectives;2022-09-14